We are live on ! Find out more
CTC

Central Trust Company Portfolio holdings

AUM $5.08B
1-Year Est. Return 25.65%
This Fund
S&P 500
This Quarter Est. Return
+2.14%
1 Year Est. Return
+25.65%
3 Year Est. Return
+74.65%
5 Year Est. Return
+97.11%
10 Year Est. Return
+319.6%
AUM
$1.51B
AUM Growth
+$9.99M
Cap. Flow
-$12.7M
Cap. Flow %
-0.84%
Top 10 Hldgs %
19.92%
Holding
1,417
New
217
Increased
264
Reduced
441
Closed
109

Sector Composition

Rank Sector Weight
1 Healthcare 12.62%
2 Industrials 12.48%
3 Technology 11.81%
4 Consumer Staples 11.77%
5 Financials 9.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OREX
1301
DELISTED
Orexigen Therapeutics, Inc.
OREX
$0 ﹤0.01%
200
KMI.WS
1302
DELISTED
Kinder Morgan Inc
KMI.WS
-311
Closed
WWAV
1303
DELISTED
The WhiteWave Foods Company
WWAV
-1,280
Closed -$72K
BQI
1304
DELISTED
OILSANDS QUEST INC COM STK
BQI
-300
Closed
EE
1305
DELISTED
El Paso Electric Company
EE
-90
Closed -$5K
DO
1306
DELISTED
Diamond Offshore Drilling
DO
$0 ﹤0.01%
21
WOOF
1307
DELISTED
VCA Inc.
WOOF
-30
Closed -$3K
MNR
1308
DELISTED
Monmouth Real Estate Investment Corp
MNR
-3,273
Closed -$47K
RNWK
1309
DELISTED
RealNetworks Inc
RNWK
$0 ﹤0.01%
+1
New +$4
FRP
1310
DELISTED
FAIRPOINT COMMUNICATIONS INC.
FRP
-29
Closed
MKTY
1311
DELISTED
MECHANICAL TECHNOLOGY INC COM STK
MKTY
$0 ﹤0.01%
+5
New

Similar funds

Central Trust Company's Q2 2017 Portfolio in Review

As of Q2 2017, Central Trust Company held 1,417 positions worth $1.51B, up 0.66% from $1.5B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Central Trust Company's Q2 2017 filing shows 217 new, 264 increased, 441 reduced and 109 closed positions. Its largest new stake was Abiomed Inc: 2,855 shares worth $409K. The largest sale was Xilinx Inc, an estimated $2.97M.

By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 12% a quarter earlier, followed by Industrials and Technology.

  • Central Trust Company's largest Q2 2017 buy was Abiomed Inc: 2,855 shares worth $409K.
  • Central Trust Company added most to iShares Gold Trust in Q2 2017, an estimated $5.65M increase.
  • Central Trust Company's biggest Q2 2017 reduction was Xilinx Inc, cutting an estimated $2.97M.
  • Central Trust Company fully exited Zayo Group Holdings, Inc. in Q2 2017, selling an estimated $91K.
  • Central Trust Company's ten largest holdings make up 20% of its $1.51B portfolio in Q2 2017.
  • Central Trust Company opened 217 new positions and closed 109 in Q2 2017.
  • Central Trust Company's portfolio value rose 0.66% quarter-over-quarter to $1.51B.

Based on Central Trust Company's 13F filing for Q2 2017, filed 14 Jul 2017.